Boston, MA -- (SBWire) -- 06/15/2013 --Adocia, formerly Proteins & Peptides Management S.A.S. is a biotechnology company. It specializes in insulin therapy and the treatment of the diabetic foot ulcer. The company controls the activity of therapeutic proteins through its BioChaperone state-of-the-art technological platform. Its pipeline products include BioChaperone PDGF for chronic wound healing, BioChaperone insulins for insulinotherapy and BioChaperone for monoclonal antibodies. The company has completed two phases I and II studies on the formulation of a fast-acting human insulin and has received adequate phase I/II results on a diabetic foot ulcer-healing product. Adocia is headquartered in Lyon, France.
With the positive results of the phase II clinical trial in India, the company, he company has filed a dossier for a phase III clinical trial which is under review of (Drugs Controller General of India. It announced its phase III development program of its product, BioChaperone PDGF-BB for the treatment of diabetic foot ulcer (DFU).
View Full Report Details and Table of Contents
This report is a source for data, analysis and actionable intelligence on the Adocia portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Medical Devices research reports at Fast Market Research
You may also be interested in these related reports:
- GE Healthcare - Product Pipeline Analysis , 2013 Update
- Philips Healthcare - Product Pipeline Analysis, 2013 Update
- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2013 Update
- Siemens Healthcare - Product Pipeline Analysis, 2013 Update
- Qiagen N.V. (QIA) - Product Pipeline Analysis, 2013 Update
- Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis, 2013 Update
- VentriPoint, Inc. - Product Pipeline Analysis, 2013 Update
- C. R. Bard, Inc. (BCR) - Product Pipeline Analysis, 2013 Update
- Alere Inc. (ALR) - Product Pipeline Analysis, 2013 Update
- Covidien plc (COV) - Product Pipeline Analysis, 2013 Update
Now Available: Adocia (ADOC) - Product Pipeline Analysis, 2013 Update
New Medical Devices research report from GlobalData is now available from Fast Market Research